A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma-Reference-Cited by-同舟云学术

A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma

Published:2010-03 Issue:3 Volume:36 Page:257-263
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology (EJSO)
language:en
Short-container-title:European Journal of Surgical Oncology (EJSO)

Author:

Peng Z.-W.,Chen M.-S.,Liang H.-H.,Gao H.-J.,Zhang Y.-J.,Li J.-Q.,Zhang Y.-Q.,Lau W.Y.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference30 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Increase in primary liver cancer in the UK, 1979–94;Taylor-Robinson;Lancet,1997

3. Rising incidence of hepatocellular carcinoma in the United States;El-Serag;N Engl J Med,1999

4. Practice guidelines committee, American association for the study of liver diseases. Management of hepatocellular carcinoma;Bruix;Hepatology,2005

5. Hepatocellular carcinoma;Llovet;Lancet,2003

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on Cholangiocarcinoma;Digestive Disease Interventions;2022-07-11

2. Combining Transarterial Radioembolization (TARE) and CT-Guided High-Dose-Rate Interstitial Brachytherapy (CT-HDRBT): A Retrospective Analysis of Advanced Primary and Secondary Liver Tumor Treatment;Cancers;2021-12-24

3. Interventional Radiology Therapies for Intrahepatic Cholangiocarcinoma;Diagnosis and Management of Cholangiocarcinoma;2021

4. Risk factors of recurrence and poor survival in curatively resected hepatocellular carcinoma with microvascular invasion;Advances in Clinical and Experimental Medicine;2020-08-04

5. A comparison between radiofrequency ablation combined with transarterial chemoembolization and surgical resection in hepatic carcinoma: A meta-analysis;Journal of Cancer Research and Therapeutics;2019